Clinical trial

Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study

NCT00362765

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-10-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2006-10-01Date precision: month

Registry last updated2008-08-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Dyslipidemiaunresolved

Interventions

FenofibrateDRUG · verified · RxNorm: fenofibrate

MetforminDRUG · verified · RxNorm: metformin

PlaceboDRUG

Sponsors & collaborators

Solvay Pharmaceuticalslead sponsor

Mapped research locations

DublinIreland1 PisaItaly1 TurkuFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00362765 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.